These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2477915)

  • 1. Multiple sclerosis patients have a high frequency of an HLA-DQ beta epitope defined by a human-human hybridoma antibody.
    Kolstad A; Hannestad K; Vandvik B; Vartdal F
    Tissue Antigens; 1989 May; 33(5):546-9. PubMed ID: 2477915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two HLA-DQ-specific human-human hybridoma antibodies (TrG6;TrC5) define epitopes also expressed by a transcomplementing hybrid DQ molecule (DQw7 alpha/DQw4 beta).
    Kolstad A; Johansen B; Hannestad K
    Hum Immunol; 1989 Jan; 24(1):15-29. PubMed ID: 2464569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3.
    Kolstad A; Hansen T; Hannestad K
    Hum Immunol; 1987 Nov; 20(3):219-31. PubMed ID: 2830209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.
    Parkkonen P; Hyöty H; Ilonen J; Reijonen H; Ylä-Herttuala S; Leinikki P
    Clin Exp Immunol; 1994 Feb; 95(2):287-93. PubMed ID: 7508347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytotoxic human hybridoma monoclonal antibody (TrJ6) defining an epitope expressed by HLA-DQ4 and -DQ5.
    Ge J; Hannestad K
    Hum Immunol; 1994 Feb; 39(2):106-12. PubMed ID: 7513681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human monoclonal hybridoma antibody (TrJ1) specific for HLA-DQ2.
    Ge J; Bartnes K; Hannestad K
    Tissue Antigens; 1993 Feb; 41(2):81-5. PubMed ID: 8386401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human-human hybridoma (Tr7E2) producing cytotoxic antibody to HLA-DQw1.
    Hansen T; Kolstad A; Mathisen G; Hannestad K
    Hum Immunol; 1987 Dec; 20(4):307-20. PubMed ID: 2449413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-barr virus: environmental trigger of multiple sclerosis?
    Lünemann JD; Kamradt T; Martin R; Münz C
    J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the fine specificity of peptide antibodies to HLA-DQ beta-chain molecules.
    Petersen JS; Atar D; Karlsen A; Kofod H; Dyrberg T
    Biomed Biochim Acta; 1990; 49(12):1223-32. PubMed ID: 1711320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
    Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
    Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II DQ epitopes.
    Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
    Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C
    J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytotoxic human-human hybridoma antibody (TrC7) specific for HLA-A29.
    Kolstad A; Bratlie A; Hannestad K
    Tissue Antigens; 1989 May; 33(5):542-5. PubMed ID: 2552611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.